By Abdullahi Jalalludeen
The National Agency for Food and Drug Administration and Control NAFDAC has reaffirms it’s commitment towards curtailing the spread of counterfeit medicines across the country.
The Director General of the Agency Professor Mojisola Christianah Adeyeye disclosed this during the opening ceremony of a two-day sensitization and awareness workshop held in Kano.
Professor Mojisola Christianah who was represented by the Director Post Marketing Pharmacist Bitrus Fraden said NAFDAC has introduced three groundbreaking initiatives aimed at fine tuning modalities of addressing the spread of counterfeit Drugs in the country ,which includes the NAFDAC Greenbook, Traceability Regulation 2024, and Pediatric Regulation 2024.
The Director General emphasized the need for stakeholders to support these initiatives, which aim to ensure the provision of quality, safe, and efficacious medical products to Nigerians.
“The NAFDAC Greenbook is an online resource that enables consumers to verify the authenticity of medical products. By searching for a product’s name, brand name, or registration number, users can confirm whether the product has been registered by NAFDAC and is considered authentic. This tool serves as a vital resource for consumer protection, helping individuals avoid potentially fake or substandard products.”
“Traceability Regulation 2024: A Game-Changer in Combating Counterfeit Medicines”
“The NAFDAC (Pharmaceutical Products) (Traceability) Regulations, 2024, provide a legal framework for tracking and tracing medical products throughout the supply chain.”
She said Nigeria is the first country in Africa to adopt the technology, which enables stakeholders to detect and reject SF products.
The project has already shown promising results, with the successful recall of substandard COVID-19 vaccines within 24 hours.
“The NAFDAC Pediatric Regulation 2024 is a specialized regulation that addresses the unique needs of children. This regulation builds upon the existing Registration regulation, providing additional safeguards to ensure the safety and efficacy of medical products for children.”
On her part a Deputy director Regina Garba said the objective of the workshop is to sensitize stakeholders on the collaboration in that aspect.
North West Coordinator of NAFDAC Mr Fadi Nantim Mullah said the purpose of holding the workshop in the zone was because of the prevalence nature of drugs manufacturers more especially in Kano.
Leave a Reply